Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-112490·HBM Healthcare Investments (Cayman) Ltd.
Schedule 13G ownership disclosure
Y-MABS THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 984241109
Event date: 2025-09-30
- Filing-level shares
- 0.00
- Percent of class
- 0%
- HBM Healthcare Investments (Cayman) Ltd.
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-112490
- Form type
- SCHEDULE 13G/A
- Filer
- HBM Healthcare Investments (Cayman) Ltd.
- CIK
- CIK 1232258
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership